[go: up one dir, main page]

WO2018199279A1 - Procédé de détermination du fait qu'un un micro-organisme est vivant ou mort à l'aide d'un précurseur d'arn ribosomique - Google Patents

Procédé de détermination du fait qu'un un micro-organisme est vivant ou mort à l'aide d'un précurseur d'arn ribosomique Download PDF

Info

Publication number
WO2018199279A1
WO2018199279A1 PCT/JP2018/017145 JP2018017145W WO2018199279A1 WO 2018199279 A1 WO2018199279 A1 WO 2018199279A1 JP 2018017145 W JP2018017145 W JP 2018017145W WO 2018199279 A1 WO2018199279 A1 WO 2018199279A1
Authority
WO
WIPO (PCT)
Prior art keywords
oligonucleotide
base sequence
seq
genus
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2018/017145
Other languages
English (en)
Japanese (ja)
Inventor
清水　則夫
健 渡邊
森尾　友宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Medical and Dental University NUC
Original Assignee
Tokyo Medical and Dental University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Medical and Dental University NUC filed Critical Tokyo Medical and Dental University NUC
Priority to JP2019514648A priority Critical patent/JPWO2018199279A1/ja
Publication of WO2018199279A1 publication Critical patent/WO2018199279A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food

Definitions

  • the present invention relates to an oligonucleotide set for determining the survival of microorganisms and a method for determining the survival of microorganisms.
  • microbial contamination inspection is indispensable for the manufacture of sterile preparations.
  • the “sterility test method” which is a general test method of the Japanese Pharmacopoeia, stipulates that the culture should be carried out for 14 days or more, and has a drawback that it takes a long time for the test. Therefore, the need for an inspection method that can quickly grasp the contamination status of microorganisms is very high.
  • the method of testing microorganisms using gene amplification reaction (PCR) is rapid, but there are many cases where materials and reagents themselves are contaminated with dead microorganisms or DNA. It cannot be said that it can be done. Therefore, establishment of a test system that can distinguish between live bacteria and dead bacteria is required.
  • a ribosomal RNA precursor is a product transcribed from a ribosomal RNA gene, and becomes a mature ribosomal RNA (rRNA) molecule after cleavage and chemical modification.
  • rRNA ribosomal RNA
  • Methods for detecting microorganisms that target the sequence of pre-rRNA, which is the primary transcript before maturation of rRNA, have been reported so far.
  • Patent Document 1 discloses a method for detecting mycobacteria using a probe that hybridizes with rDNA, precursor rRNA, or rRNA target sequence of mycobacteria.
  • the detection target is only mycobacteria, and there is no specific description of the target sequence of the precursor rRNA.
  • Patent Document 2 discloses a method for detecting a living microorganism in a sample based on a difference in expression level of a target rRNA precursor between a nutritionally stimulated aliquot and a non-stimulated control aliquot.
  • Patent Document 3 discloses a method in which primers specific to the ribosome region and spacer region of a pre-rRNA of a microorganism are designed and the presence of viable bacteria in a sample is detected by reverse transcription and quantitative PCR.
  • the types of bacteria that can be detected are limited, and a special treatment is required before measurement, so that the methods are not quick and accurate.
  • an object of the present invention is to provide means capable of quickly and accurately determining the viability of a wide range of microbial species.
  • pre-rRNA ribosomal RNA precursor
  • a ribosomal RNA precursor transcribed from a ribosomal RNA gene of a microorganism such as a bacterium or a fungus
  • pre-rRNA ribosomal RNA precursor
  • a microorganism such as a bacterium or a fungus
  • the spacer region was determined for bacteria.
  • a region that has a base sequence common to bacteria in the 23S rRNA gene and 5S rRNA gene, and a base sequence common to fungi in the 18S rRNA gene and 5.8S rRNA gene with the spacer region in between Each region was found, and an oligonucleotide set composed of a primer pair and a probe was designed based on the base sequence in the region.
  • the present invention includes the following inventions.
  • a set of oligonucleotides for determining the survival of microorganisms comprising oligonucleotides designed in two ribosomal RNA gene regions sandwiching the spacer region of a ribosomal RNA precursor (pre-rRNA).
  • pre-rRNA ribosomal RNA precursor
  • the microorganism is a bacterium, and the oligonucleotide set includes a primer pair comprising the following oligonucleotide (a) and the oligonucleotide (b), and a probe comprising the following oligonucleotide (c):
  • oligonucleotide consisting of a base sequence containing at least 15 consecutive bases in the base sequence shown in SEQ ID NO: 1
  • oligonucleotide consisting of a base sequence containing at least 15 contiguous bases in the base sequence shown in SEQ ID NO: 2 and a sequence
  • Oligo consisting of a base sequence containing at least 15 bases in the base sequence shown in SEQ ID NO: 4 or its complementary sequence
  • Nucleotide Nucleotide (5)
  • the microorganism is a fungus
  • the oligonucleotide set comprises a primer pair comprising the following oligonucleotide (d) and the oligonucleotide (e), and a probe comprising the following oligonucleotide (f):
  • the viability determination oligonucleotide set of microorganisms crab according comprises at least one set, microbial viability determination kit.
  • RT-PCR amplification is performed using the oligonucleotide set for determining the viability of microorganisms as described in any one of (1) to (5), and the resulting amplification product is detected.
  • a method for determining the viability of a microorganism characterized by quantifying.
  • an oligonucleotide set that can quickly and accurately determine whether a microorganism in a specimen is viable or dead, and a method for determining a living microorganism using the oligonucleotide set. Therefore, the present invention is useful for microbial contamination inspection at food factories and medical sites.
  • FIG. 1A shows a design region of a bacterial life / death determination oligonucleotide (forward primer, probe) in the 23S rRNA gene of a bacterial ribosomal RNA precursor (pre-rRNA).
  • FIG. 1B shows the design region of a bacterial life / death judgment oligonucleotide (reverse primer) in the 5S rRNA gene of a bacterial ribosomal RNA precursor (pre-rRNA).
  • Fig. 2-1 shows that E.
  • coli is sterilized by heating at 65 ° C for 30 minutes, then at 37 ° C for a certain time [1 hour (1 hr), 3 hours (3 hr), 6 hours (6 hr), 1 day (d1), 2 days (d2), 3 days (d3), 4 days (d4), 5 days (d5), 6 days (d6)] amplification obtained by oligonucleotide set 1 for bacteria (product of the present invention) A curve is shown (DW: negative control).
  • Escherichia coli is sterilized by heating at 65 ° C for 30 minutes, and then at 37 ° C for a certain period of time [1 hour (1 hr), 3 hours (3 hr), 6 hours (6 hr), 1 day (d1), 2 days (d2), 3 days (d3), 4 days (d4)] shows amplification curves obtained by performing real-time PCR using oligonucleotide set 2 (comparative product) for the incubated samples (NC: negative control) ).
  • 3A shows Kanamycin of Escherichia coli, high temperature heat sterilization (95 ° C for 10 minutes), low temperature heat sterilization (65 ° C for 30 minutes), and then at 37 ° C for a certain time [1 hour (1h), 3 hours (3h), 6 hours (6h), 1 day (day 1), 2 days (day 2), 3 days (day 3), 4 days (day 4)] copies of ribosomal RNA precursor (pre-rRNA) measured by incubation Indicates a number.
  • pre-rRNA ribosomal RNA precursor
  • 3B shows the results of sterilization treatment of Escherichia coli kanamycin, high temperature heat sterilization (95 ° C for 10 minutes), and low temperature heat sterilization (65 ° C for 30 minutes) at 37 ° C for a certain time [1 hour (1h), 3 hours (3h), 6 hours (6h), 1 day (day 1), 2 days (day 2), 3 days (day 3), 4 days (day 4)] shows the number of viable bacteria measured by incubation.
  • FIG. 4-1 shows the design region of fungal ribosomal RNA precursor (pre-rRNA) 18S rRNA gene oligonucleotides (forward primer, probe) and fungal ribosomal RNA precursor (pre-rRNA) 3) shows the design region of the oligonucleotide (reverse primer) for fungal viability determination in the 5.8S rRNA gene.
  • Fig. 4-2 shows the design region of fungal ribosomal RNA precursor (pre-rRNA) 18S rRNA gene, and the fungal ribosomal RNA precursor (pre-rRNA). 3) shows the design region of the oligonucleotide (reverse primer) for fungal viability determination in the 5.8S rRNA gene.
  • Fig.4-3 shows the design region of fungal ribosomal RNA precursor (pre-rRNA) 18S rRNA gene for oligonucleotides (forward primer, probe) for fungal life and death, and fungal ribosomal RNA precursor (pre-rRNA) 3) shows the design region of the oligonucleotide (reverse primer) for fungal viability determination in the 5.8S rRNA gene.
  • Oligonucleotide set for determining the viability of microorganisms is composed of oligonucleotides designed in two ribosomal RNA gene regions sandwiching the spacer region of a ribosomal RNA precursor (pre-rRNA).
  • pre-rRNA ribosomal RNA precursor
  • the base length of the oligonucleotide is not limited, but is usually 15 to 30 bases, preferably 18 to 25 bases in the case of a primer, and 10 to 30 bases in the case of a probe.
  • the oligonucleotide set for life / death determination of microorganisms of the present invention when the life / death determination target is a bacterium, the 23S rRNA gene and the 5S rRNA gene base sequence across the spacer region of the bacterial ribosomal RNA precursor (pre-rRNA) It is composed of two or more kinds of oligonucleotides designed based on the found common base sequences.
  • the oligonucleotide set for determining the viability of the microorganism of the present invention when the life / death determination target is a fungus, includes an 18S ⁇ rRNA gene and a 5.8S rRNA gene with a spacer region of a fungal ribosomal RNA precursor (pre-rRNA) sandwiched between them. It is composed of two or more kinds of oligonucleotides designed based on highly common base sequences found in the base sequences.
  • the base region information of the 23S rRNA gene and the 5S ⁇ ⁇ rRNA gene with the spacer region in between, and the typical fungus with the spacer region in between. Obtain the base sequence information of 18S rRNA gene and 5.8S rRNA gene.
  • Base sequence information may be obtained from a database (DDBJ, NCBI, etc.), or may be obtained by directly analyzing the base sequence.
  • the base sequence having high commonality can be specified by aligning and comparing a plurality of obtained base sequences.
  • alignment software for example, CLUSTALW, URL: http://www.ddbj.nig.ac.jp/
  • a primer is designed based on the identified highly common base sequence.
  • Primers are designed in consideration of oligonucleotide length, GC content, Tm value, complementarity between oligonucleotides, secondary structure in oligonucleotides, and the like.
  • commercially available software for primer design such as Oligo TM [manufactured by National Biosciences Inc. (USA)], GENETYX [manufactured by Software Development Co., Ltd. (Japan)], etc. can also be used.
  • the specific design criteria for the primers adopted are as follows.
  • the primer length is in the range of 15 to 30 bases in order to allow specific annealing with the template cDNA.
  • (b) Avoid complementary sequences between both primers so as not to form dimers or conformations.
  • (c) Avoid self-complementary sequences to prevent the formation of hairpin structures within the primer.
  • the GC content should be about 50% so that GC-rich or AT-rich is not unevenly distributed in the primer.
  • the homology between the nucleotide sequence at the 3 ′ end of the primer and the template cDNA sequence is high.
  • the probe design is based on software that comes with commercial real-time PCR instruments such as ABI Prism 7900HT Real-time PCR System (Life Technologies Japan Co., Ltd.) and TaqMan Universal PCR Master Master (Life Technologies Japan Co., Ltd.). What is necessary is just to carry out based on the protocol attached to a commercially available real-time PCR reagent.
  • the probe design criteria are that the GC content should be within the range of 20-80%, avoid the continuation of G or C of 4 bases or more in the sequence, and the Tm value of the corresponding primer pair. Also, it may be set higher by about 8 to 10 ° C.
  • oligonucleotides that serve as the primers or probes described above are prepared by methods known in the art as methods for synthesizing oligonucleotides, such as the phosphoramidite method, the H-phosphonate method, etc., using a commonly used automatic DNA synthesizer. It is possible to synthesize.
  • the oligonucleotide constituting the oligonucleotide set of the present invention is an oligonucleotide consisting of the base sequence shown in SEQ ID NO: 1, 2, or 3 above, an oligonucleotide consisting of the base sequence shown in SEQ ID NO: 4 or a complementary sequence thereof, or In addition to the oligonucleotide consisting of the base sequence shown in SEQ ID NO: 5, 6, 7, 8, or 9 above, the oligonucleotide consisting of the base sequence shown in SEQ ID NO: 10 or a complementary sequence thereof, as well as microorganisms based on pre-rRNA detection Those homologous oligonucleotides may be used as long as they can function as a life or death judgment primer or probe.
  • the oligonucleotide constituting the oligonucleotide set (for bacteria) of the present invention is an oligonucleotide consisting of a base sequence comprising at least 15 consecutive bases in the base sequence shown in SEQ ID NO: 1, and a continuous in the base sequence shown in SEQ ID NO: 2.
  • An oligonucleotide consisting of a base sequence containing at least 15 bases an oligonucleotide consisting of a base sequence containing at least 15 consecutive bases in the base sequence shown in SEQ ID NO: 3, a base sequence shown in SEQ ID NO: 4 or at least a contiguous sequence thereof It is an oligonucleotide consisting of a base sequence containing 15 bases.
  • the oligonucleotide constituting the oligonucleotide set (for fungus) of the present invention is an oligonucleotide comprising a base sequence comprising at least 15 consecutive bases in the base sequence shown in SEQ ID NO: 5, and a continuous in the base sequence shown in SEQ ID NO: 6.
  • An oligonucleotide consisting of a base sequence, an oligonucleotide consisting of a base sequence containing at least 15 bases in the base sequence shown in SEQ ID NO: 9, a base containing at least 15 bases in a base sequence shown in SEQ ID NO: 10 or a complementary sequence thereof Is an oligonucleotide that consists of a sequence.
  • the base sequence of the homologous oligonucleotide may include at least 15 consecutive bases in the base sequences shown in SEQ ID NOs: 1 to 10 or its complementary sequence, but the total length is preferably 30 bases or less. There are no particular limitations on the site (3 'terminal side, 5' terminal side) in the oligonucleotide having at least 15 consecutive nucleotides.
  • the probe of the present invention may be labeled with a labeling substance for detecting and quantifying a fluorescent signal derived from a target amplification product of bacteria to be detected.
  • a labeling substance for detecting and quantifying a fluorescent signal derived from a target amplification product of bacteria to be detected.
  • the labeled probe include a TaqMan probe, a molecular beacon probe, and a cycling probe, and a TaqMan probe is preferable.
  • the TaqMan probe is a probe in which the 5 ′ end is modified with a fluorescent substance (reporter fluorescent dye) and the 3 ′ end is modified with a quenching substance (quencher fluorescent dye).
  • the molecular beacon probe is a probe that can have a stem-loop structure in which the 5 ′ end is modified with a fluorescent substance (reporter fluorescent dye) and the 3 ′ end is modified with a quenching substance (quencher fluorescent dye).
  • the cycling probe is a probe composed of RNA and DNA in which the 5 ′ end of an oligonucleotide is modified with a fluorescent substance (reporter fluorescent dye) and the 3 ′ end is modified with a quenching substance (quencher fluorescent dye).
  • reporter fluorescent dyes for the TaqMan probe examples include 6-FAM (6-carboxyfluorescein), TET (6-carboxy-4, 7, 2 ', 7'-tetrachlorofluorescein), HEX (6-carboxy-2' , 4 ', 7', 4,7-hexachlorofluorescein) and the like
  • quencher fluorescent dyes examples include 6-carboxytetramethylrhodamine (TAMRA), 6-carboxy-X-rhodamine Rhodamine fluorescent dyes such as (ROX), [(4- (2-nitro-4-methyl-phenyl) -azo) -yl-((2-methoxy-5-methyl-phenyl) -azo)]-aniline ( BHQ) and the like.
  • TAMRA 6-carboxytetramethylrhodamine
  • ROX 6-carboxy-X-rhodamine Rhodamine fluorescent dyes
  • BHQ 2-methoxy-5-methyl-phenyl
  • the oligonucleotide set can be made into a kit.
  • the kit of the present invention only needs to contain at least one of the above-mentioned oligonucleotide sets, and if an appropriate set is appropriately selected from these oligonucleotide sets depending on the type and number of microorganisms for determining life and death, Good.
  • the kit of the present invention includes molecular weight markers that can be used for gene amplification and confirmation of amplification products, RNA extraction reagents, PCR buffers such as PCR buffers and DNA polymerase, labeling substances, and specimens as necessary. (Standard strains, etc.), sterilized water, instructions, etc. may be included.
  • the reagent in the kit may be a solution or a lyophilized product.
  • Method for Determining Microorganism Life and Death there is also provided a method for determining microbe life and death in a specimen using the above-described oligonucleotide set for life and death determination of microorganisms based on pre-rRNA detection.
  • a method for determining the life or death of bacteria is a method using an RNA extracted from a specimen as a template, an oligonucleotide (forward primer) comprising a base sequence containing at least 15 consecutive bases in the base sequence shown in SEQ ID NO: 1, Mixture (reverse primer) of an oligonucleotide consisting of a base sequence containing at least 15 bases in the base sequence shown in SEQ ID NO: 2 and an oligonucleotide consisting of a base sequence containing at least 15 bases in the base sequence shown in SEQ ID NO: 3
  • a probe comprising an oligonucleotide comprising a step of performing RT-PCR amplification using a primer pair comprising: and a base sequence comprising at least 15 consecutive bases in the base sequence shown in SEQ ID NO: 4 or a complementary sequence thereof.
  • RNA forward primer
  • SEQ ID NO: 5 RNA extracted from a specimen as a template
  • SEQ ID NO: 6 An oligonucleotide consisting of a base sequence containing at least 15 bases in the base sequence shown in FIG. 8, an oligonucleotide consisting of a base sequence containing at least 15 bases in the base sequence shown in SEQ ID NO: 7, and a continuation in the base sequence shown in SEQ ID NO: 8.
  • RT- using a primer pair consisting of a mixture of oligonucleotides comprising a base sequence comprising at least 15 bases and an oligonucleotide comprising a base sequence comprising at least 15 consecutive bases in the base sequence shown in SEQ ID NO: 9 (reverse primer) Perform PCR amplification Including process and the resulting detected using a probe consisting of an oligonucleotide consisting of the nucleotide sequence comprising at least 15 consecutive bases of the amplified product in the nucleotide sequence or its complementary sequence shown in SEQ ID NO: 10 and quantifying step.
  • the type of “specimen” is not particularly limited as long as there is a possibility that microorganisms are mixed or infected, and the presence can be detected by amplification of a specific region by PCR.
  • examples include pharmaceuticals, medical materials or medical instruments, biological samples, and environmental samples.
  • the medical material or medical instrument include catheters, stents, artificial blood vessels, artificial organs, blood bags, bone prostheses, surgical tools, embolic devices, guide wires, and the like
  • biological samples include blood (whole blood, plasma, Serum), saliva, spinal fluid, urine, milk and other body fluids, tissues, cell cultures, and the like
  • environmental samples include air, soil, water, and the like.
  • the sample may be the sample or product itself as described above, or may be a diluted or concentrated sample or a pretreated sample. Examples of the pretreatment include heat treatment, filtration, and centrifugation.
  • the bacterium capable of determining whether it is alive or dead by the method of the present invention includes both gram-positive bacteria and gram-negative bacteria. Specifically, Escherichia genus, Bacillus genus, Salmonella genus, Pseudomonas genus, Clostridium genus, Neisseria genus, Streptococcus genus, Staphylococcus genus (Staphylococcus) genus, Mycobacterium genus, Enterobacter genus, Enterococcus genus, Porphyromonas genus, Yersinia genus, Haemophilus genus, Helicobacter genus Genus, Citrobacter genus, Campylobacter genus, Borrelia genus, Serratia genus, Deinococcus genus, Shigella genus, Aeromonas genus, Eikenella Genus, Lactobacil (Lactobacillus
  • fungi examples include Aspergillus spp., Alternaria spp., Absidia spp., Basidobolus spp., Candida spp., Chlamydoabsidia spp.
  • Conidobolus genus Conidobolus genus, Cokeromyces genus, Cryptococcus genus, Cunninghamella genus, Emericella genus, Echinos sporangium genus, Fusarium genus The genus Paula, Lichtheimia, Microsporum, Mucor, Malassezia, Moltierella, Pseudallescheria, Paecilomyces ,new Pneumocystis, Rhizopus, Rhizomucor, Rhodotorula, Saksenaea, Trichosporon, histoplasma, cocidiodes, C (Blastomyces) genus, Paracoccidioides genus, Penicillium genus, Sporothrix genus, Trichophyton genus, Epidermophyton genus, Malassezia genus, Hyalora And fungi belonging to the genus Cladosporium, but are not limited thereto
  • RNA extraction method As a method for extracting RNA from a specimen, a method known in the art, for example, an RNA extraction method using guanidine isothiocyanate, phenol and chloroform can be used. Alternatively, a commercially available RNA extraction reagent may be used.
  • a method for synthesizing cDNA from RNA is also well known in the art.
  • a commercially available random primer is used as a primer, and cDNA is synthesized using reverse transcriptase in the presence of dNTPs.
  • the reverse transcriptase for example, SuperScript II (manufactured by Invitrogen), Thermoscript RT, AMV reverse transcriptase, MMLV reverse transcriptase, etc. can be used.
  • Commercially available reagents or kits for reverse transcription can also be used as appropriate.
  • the reaction conditions for the reverse transcription reaction can be appropriately set according to the reverse transcriptase used.
  • the reaction can be performed at 42 ° C. for 40 to 60 minutes.
  • the reverse transcriptase may be inactivated. Inactivation of reverse transcriptase can be performed by heat treatment or chemical treatment.
  • PCR amplification is performed using the synthesized cDNA as a template and the primer pairs included in the oligonucleotide set of the present invention.
  • PCR amplification is not particularly limited except that the above primer pairs are used, and may be performed according to a conventional method. Specifically, a cycle including denaturation of template DNA, annealing of the primer to the template, and primer extension reaction using a thermostable enzyme (DNA polymerase such as Taq polymerase or Tth DNA polymerase from Thermus thermophilus) is repeated. To amplify a fragment containing a specific gene sequence of bacterial or fungal pre-rRNA.
  • DNA polymerase such as Taq polymerase or Tth DNA polymerase from Thermus thermophilus
  • composition of the PCR reaction solution and the PCR reaction conditions should be determined by a person skilled in the art based on preliminary experiments, etc. under conditions such that a PCR amplification product can be obtained with high sensitivity in PCR using the above primer pairs. Can be selected and set appropriately.
  • Methods for selecting appropriate PCR reaction conditions based on the Tm of the primer are well known in the art, for example, first a denaturation reaction at 94 ° C. for 5 minutes and then at 94 ° C. for 50 seconds (denaturation).
  • the extension reaction can be carried out at 55 ° C. for 50 seconds (annealing), 72 ° C. for 1 minute (extension) for 30 cycles, and finally 72 ° C. for 1 minute.
  • RNA is converted to cDNA and PCR is performed ( RT-PCR) LightCycler DX480 (Roche) and Takara One Step RT-PCR Kit AMV (TAKARA), which can be carried out continuously in one tube, can be preferably used.
  • the above PCR is preferably performed by real-time PCR.
  • Real-time PCR is a technique in which PCR is performed using a real-time PCR apparatus, and amplification by PCR is measured over time to quantify DNA as a template based on the amplification rate.
  • a device dedicated to real-time PCR in which a thermal cycler and a spectrofluorometer are integrated, is usually used.
  • PCR is performed using a known amount of DNA that has been serially diluted as a standard, and based on this, the number of cycles (threshold cycle; Ct value) that results in a constant amount of amplification product in the region where amplification occurs exponentially Is plotted on the vertical axis and the initial DNA amount is plotted on the horizontal axis to create a calibration curve.
  • a sample having an unknown concentration can be reacted under the same conditions to obtain a Ct value, and the target DNA amount in the sample can be measured from this value and a calibration curve.
  • the real-time PCR method includes a method using a fluorescently labeled probe and a method using a fluorescent reagent depending on the detection method of the gene amplification product.
  • Examples of methods using fluorescently labeled probes include TaqMan method, molecular beacon probe, TaqMan method using molecular probe, molecular beacon method, and cycling probe method.
  • Methods using fluorescent reagents include double-stranded DNA together with primer pairs. Examples include an intercalator method in which an intercalator such as SYBR Green I, which is a compound that emits fluorescence by binding to, is added to the PCR reaction system. Among the above methods, the TaqMan method is preferable.
  • PCR is performed by adding an oligonucleotide probe modified with a fluorescent substance (such as FAM) at the 5 ′ end and a quencher substance (such as TAMRA) at the 3 ′ end to the PCR reaction system.
  • a fluorescent substance such as FAM
  • TAMRA quencher substance
  • the TaqMan probe specifically hybridizes to the template DNA under the conditions used for the polymerase extension reaction in the PCR amplification reaction, and is degraded as the DNA strand extends, that is, the template DNA is amplified. By releasing the substance, the amount of fluorescence in the PCR solution increases.
  • the real-time PCR method can be carried out using a commercially available real-time PCR kit or real-time PCR apparatus based on the usual methods known to those skilled in the art, except that the above-mentioned oligonucleotide set is used, according to the operating instructions attached to them. That's fine.
  • QuantiTect SYBR Green Mix Qiagen
  • ABI Prism 7500 FastAppReal-Time PCRTaSystem (Applied Biosystems)
  • Takara-Bio ⁇ Thermal Cycler Dice Real Time System II etc. be able to.
  • Example 1 Preparation of Bacterial Life / Death Oligonucleotide Set Preparation
  • the following bacterial ribosomal RNA that can be determined for the design of a bacterial life / death determination oligonucleotide set (primer and probe) based on rRNA precursor detection
  • Precursor sequence information was downloaded from GenBank, and alignment was performed using Allele ID v7.80 (premier biosoft) to search for regions having a base sequence highly common among bacterial species.
  • the region from 6804 to 6780th in the nucleotide sequence of the 23S rRNA gene identified as a region having a highly common nucleotide sequence (FIG. 1A), and 7644 to the nucleotide sequence of the 5S rRNA gene.
  • Specific primers and probes were designed using Allele v 7.80 (premier biosoft) based on the base sequence of the region up to the 7685th region (Fig. 1B).
  • the oligonucleotide consisting of the base sequence shown in SEQ ID NO: 1 as a 23S rRNA common forward primer for general bacterial rRNA precursors, and the base sequences shown in SEQ ID NO: 2 and SEQ ID NO: 3 as 5S rRNA common reverse primers for general bacterial rRNA precursors
  • the following oligonucleotide consisting of the base sequence shown in SEQ ID NO: 4 was designed as a 23S rRNA common probe for general bacterial rRNA precursors.
  • the forward primer and the probe are the same as described above, and the reverse primer is an oligonucleotide having the nucleotide sequences shown in SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, and SEQ ID NO: 14 Set 2) was designed.
  • Example 2 Determination of E. coli life or death Method (1) Preparation of Test Sample A viable cell suspension (1 ⁇ 10 6 CFU / ml) of E. coli JCM1649 was prepared using physiological saline. Place 500 ⁇ L of this Escherichia coli suspension in a 1.5 ml tube, (i) high-temperature sterilization at 95 ° C. for 10 minutes, (ii) low-temperature sterilization at 65 ° C. for 30 minutes, (iii) kanamycin antibiotic A test sample was prepared by sterilizing each agent under conditions of sterilization (300 ⁇ g / ml).
  • test sample is kept at 37 ° C, 1 hour, 3 hours, 6 hours, 1 day, 2 days, 3 days, 4 days, After 5 days and 6 days, the rRNA precursor (pre-rRNA) in each test sample was measured as follows.
  • test sample was centrifuged at 5 krpm for 5 minutes, and after removing the supernatant, 500 ⁇ L of RLT buffer containing 1% mercaptoethanol was added and suspended using RNeasy mini kit (Qiagen), and then zirconia beads ( It was transferred to a 2 ml tube containing 1 piece (diameter 0.2 mm 0.5 g). After treatment with a crusher ⁇ T-12 (manufactured by TAITEC) at 3500 rpm for 5 minutes, 350 ⁇ L was transferred to a new 1.5 ml tube, and RNA was extracted according to the manual attached to the kit (including optional DNase treatment).
  • RNA sample 50 ⁇ L was treated with DNase I 5 U (Takara Bio) and 1 ⁇ Buffer 30 ° C. for 30 minutes. After the treatment, RNA was purified again. The operation method was in accordance with RNA “clean up” in the attached manual (including optional DNase treatment).
  • a master mix when using oligonucleotide set 1) shown in Table 1 below was prepared, and real-time PCR amplification was performed.
  • RT-PCR conditions After a reverse transcription (RT) reaction at 42 ° C. for 10 minutes, 45 cycles were carried out, first at 95 ° C. for 10 minutes and then at 95 ° C. for 5 seconds and 60 ° C. for 1 minute.
  • the detection and quantification of the amplification product was performed using the probe designed in Example 1 (fluorescent dye 6-FAM added to the 5 'end of the oligonucleotide and quenching dye BHQ added to the 3' end).
  • the length of the amplified product was about 400 bp.
  • TaKaRa primescript RT enzyme in Table 1 was compared. If a positive signal is detected with TaKaRa primescript RT enzyme- (without reverse transcription), DNA remains, and the rRNA precursor may not be accurately quantified. However, when it was detected with a negative control, it was cut off around the same number of cycles due to the enzyme host-derived DNA.
  • Viable count (CFU / ml) For test samples sterilized under the conditions of high-temperature heat sterilization at 95 ° C for 10 minutes and low-temperature heat sterilization at 65 ° C for 30 minutes, the specified time after sterilization (1 hour, 3 hours, 6 hours, 1 day, 2 days , 3 days, 4 days), the test samples were used for the viable count.
  • test samples sterilized with kanamycin antibiotic (300 ⁇ g / ml) remove the supernatant by centrifuging at 5 krpm for 5 minutes, then add 500 ⁇ L of LB medium without the antibiotic and add E. coli cells.
  • E. coli cells at each stage were seeded on LB agar medium and incubated overnight at 37 ° C., and cfu / ml was measured by colony count.
  • FIGS. 2-1 and 2-2 Results Amplification curves obtained by performing real-time PCR using oligonucleotide set 1 and oligonucleotide set 2 are shown in FIGS. 2-1 and 2-2, respectively.
  • oligonucleotide set 2 was judged to have low sensitivity.
  • rRNA and genomic DNA derived from the host were detected in both RT-PCR (with reverse transcription) and PCR (without reverse transcription) (FIG.
  • the oligonucleotide set 1 was established as an oligonucleotide set for determining the viability of the microorganism (bacteria) of the present invention.
  • FIG. 3A Quantitative results of rRNA precursors by real-time PCR (using oligonucleotide set 1) are shown in FIG. 3A, and the viable count results are shown in FIG. 3B.
  • the rRNA precursor was found to be 72 hours after high-temperature sterilization at 95 ° C. for 10 minutes, 48 hours after low-temperature heat sterilization at 65 ° C. for 30 minutes, and 72 hours after kanamycin treatment. It was below the detection limit.
  • FIG. 3B all the bacteria that passed 1 hour or more after any sterilization treatment were killed. From this result, when more than 72 hours have passed since the death of live bacteria, the rRNA precursor is below the detection limit, and even if bacterial DNA is detected, it is possible to distinguish between live and dead bacteria if no rRNA precursor is detected It was proved.
  • Example 3 Preparation of oligonucleotide set for determination of fungal life and death
  • the following fungal ribosomal RNAs that can be determined for the design of oligonucleotide set (primer and probe) for determination of fungal life and death based on rRNA precursor detection
  • Precursor sequence information was downloaded from GenBank, and alignment was performed using Allele ID v7.80 (premier biosoft) to search for regions having a base sequence highly common between fungal species.
  • the region has a highly common base sequence, the region from 1017 to 1071 of the base sequence of the 18S rRNA gene (Figs. 4-1 to 3), and the region of the 5.8S rRNA gene Specific primers and probes were designed using Allele v 7.80 (premier biosoft) based on the nucleotide sequence (Figs. 4-1 to 3) in the region up to the 2434-2463th of the nucleotide sequence.
  • the following oligonucleotide consisting of the nucleotide sequence shown in SEQ ID NO: 10 was designed as an 18S ⁇ ⁇ rRNA ⁇ ⁇ common probe for fungal general rRNA precursors, and the oligonucleotide set of the present invention was prepared.
  • Table 2 shows the master mix composition when real-time PCR amplification is performed using the above-mentioned oligonucleotide set for fungi.
  • the present invention can be used for microbial contamination inspection in the field of food and pharmaceutical manufacturing and medical practice.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Sustainable Development (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Le problème à la base de la présente invention concerne un moyen permettant de déterminer rapidement et avec précision le fait que des espèces microbiennes sont vivantes ou mortes sur une large plage. L'invention concerne : un ensemble d'oligonucléotides pour déterminer le fait qu'un micro-organisme est vivant ou mort, ledit ensemble comprenant des oligonucléotides conçus dans deux régions géniques d'ARN ribosomique entre lesquelles la région d'écarteur d'un précurseur d'ARN ribosomique (pré-ARNr) est prise en sandwich ; un kit pour déterminer le fait qu'un micro-organisme est vivant ou mort, ledit kit comprenant l'ensemble d'oligonucléotides ; et un procédé pour déterminer le fait qu'un micro-organisme est vivant ou mort à l'aide de l'ensemble d'oligonucléotides.
PCT/JP2018/017145 2017-04-27 2018-04-27 Procédé de détermination du fait qu'un un micro-organisme est vivant ou mort à l'aide d'un précurseur d'arn ribosomique Ceased WO2018199279A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019514648A JPWO2018199279A1 (ja) 2017-04-27 2018-04-27 リボソームｒｎａ前駆体を利用した微生物の生死判定方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-087847 2017-04-27
JP2017087847 2017-04-27

Publications (1)

Publication Number Publication Date
WO2018199279A1 true WO2018199279A1 (fr) 2018-11-01

Family

ID=63918587

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/017145 Ceased WO2018199279A1 (fr) 2017-04-27 2018-04-27 Procédé de détermination du fait qu'un un micro-organisme est vivant ou mort à l'aide d'un précurseur d'arn ribosomique

Country Status (2)

Country Link
JP (1) JPWO2018199279A1 (fr)
WO (1) WO2018199279A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024048755A1 (fr) * 2022-09-01 2024-03-07 島津ダイアグノスティクス株式会社 Procédé de test de stérilité rapide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000618A1 (fr) * 1986-07-10 1988-01-28 Toray Industries, Inc. Procede et sonde de depistage de bacteries dans des echantillons
JP2012511331A (ja) * 2008-12-10 2012-05-24 ユニヴァーシティ オブ ワシントン ｒＲＮＡ前駆体のレシオメトリック分析

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000618A1 (fr) * 1986-07-10 1988-01-28 Toray Industries, Inc. Procede et sonde de depistage de bacteries dans des echantillons
JP2012511331A (ja) * 2008-12-10 2012-05-24 ユニヴァーシティ オブ ワシントン ｒＲＮＡ前駆体のレシオメトリック分析

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GRANNEMAN, SANDER. ET AL.: "Crosstalk in gene expression: coupling and co-regulation of rDNA transcription, pre-ribosome assembly and pre-rRNA processing", CURRENT OPINION IN CELL BIOLOGY, vol. 17, no. 3, June 2005 (2005-06-01), pages 281 - 286, XP027618164 *
LEE, ZARRAZ MAY-PING. ET AL.: "rrnDB: documenting the number of rRNA and tRNA genes in bacteria and archaea", NUCLEIC ACIDS RESEARCH, vol. 37, 2009, pages D489 - D493, XP055145324 *
TOLLERVEY, DAVID: "A yeast small nuclear RNA is required for normal processing of pre-ribosomal RNA", THE EMBO JOURNAL, vol. 6, no. 13, 1987, pages 4169 - 4175, XP055529087 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024048755A1 (fr) * 2022-09-01 2024-03-07 島津ダイアグノスティクス株式会社 Procédé de test de stérilité rapide

Also Published As

Publication number Publication date
JPWO2018199279A1 (ja) 2020-03-19

Similar Documents

Publication Publication Date Title
JP2022023068A (ja) 細菌汚染を検出するための方法および組成物
AU2014286889B2 (en) Methods of targeted antibiotic susceptibility testing
JP6603956B2 (ja) ポリメラーゼ活性を指標として非精製サンプル中の微生物の存在を検出する方法
JP5238248B2 (ja) ｒＲＮＡを標的とした微生物の定量的解析方法
Byrne et al. Development of a molecular methodology to quantify Staphylococcus epidermidis in surgical wash-out samples from prosthetic joint replacement surgery
JP2023521783A (ja) Ｒｔ－ｐｃｒを用いたウイルス感染の迅速な検出
JP2010512740A (ja) 酵母種および真菌種の検出のための核酸プローブ
WO2018199279A1 (fr) Procédé de détermination du fait qu'un un micro-organisme est vivant ou mort à l'aide d'un précurseur d'arn ribosomique
EP2347013B1 (fr) Procédé pour la détection spécifique d'espèces d'arn de faible abondance dans un échantillon biologique
EP3936615A1 (fr) Procédé pour déterminer si un organisme ayant une paroi cellulaire existe et procédé pour identifier un organisme ayant une paroi cellulaire
JP2016042801A (ja) 食中毒原因菌を分離検出する方法
US20100311040A1 (en) Dna Fragments, Primers, Kits, and Methods for Amplification the Detection and Identification of Clinically Relevant Candida Species
Wolff et al. Detection of microbial diversity in endocarditis using cultivation-independent molecular techniques
JP2007075017A (ja) Ｃａｍｐｙｌｏｂａｃｔｅｒｊｅｊｕｎｉの検出法
JP2015119656A (ja) 核酸増幅法
WO2024053642A1 (fr) Procédé de détection de fusobacterium nucleatum et procédé de détection de fusobacterium nucleatum nucleatum
JP2007075018A (ja) Ｃａｍｐｙｌｏｂａｃｔｅｒｃｏｌｉの検出法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18791897

Country of ref document: EP

Kind code of ref document: A1

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2019514648

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18791897

Country of ref document: EP

Kind code of ref document: A1